Liu, Qi
Rubarth, Kerstin
Faber, Jennifer
Sulzer, Patricia
Dogan, Imis
Barkhoff, Miriam
Minnerop, Martina
Berlijn, Adam M.
Elben, Saskia
Jacobi, Heike
Aktories, Julia-Elisabeth
Huvermann, Dana M.
Erdlenbruch, Friedrich
Van der Veen, Raquel
Müller, Johanna
Nio, Enzo
Frank, Benedikt
Köhrmann, Martin
Wondzinski, Elke
Siebler, Mario
Reetz, Kathrin
Konczak, Jürgen
Konietschke, Frank
Klockgether, Thomas
Synofzik, Matthis
Röske, Sandra
Timmann, Dagmar
Thieme, Andreas https://orcid.org/0000-0001-6221-8601
Clinical trials referenced in this document:
Documents that mention this clinical trial
Subtypes of cognitive impairment in cerebellar disease identified by cross-diagnostic cluster-analysis: results from a German multicenter study
https://doi.org/10.1007/s00415-024-12831-1
Funding for this research was provided by:
German Heredo-Ataxia Society
“Freunde und Förderer der Neurologie der Universitätsmedizin Essen”
UMEA/ DFG (FU356/12-1)
The State Scholarship Fund of China (202308110231)
Deutsche Forschungsgemeinschaft (437661157, 437661157)
The Interdisciplinary Centre for Clinical Research within the faculty of Medicine at the RWTH Aachen University
Universitätsklinikum Essen
Article History
Received: 18 September 2024
Revised: 22 November 2024
Accepted: 23 November 2024
First Online: 21 December 2024
Declarations
:
: Matthis Synofzik has received consultancy honoraria from Ionis, UCB, Prevail, Orphazyme, Biogen, Servier, Reata, GenOrph, AviadoBio, Biohaven, Zevra, Lilly, and Solaxa, all unrelated to the present manuscript. All other authors declare no financial disclosures or conflicts of interest other than the funding stated concerning the research covered in this manuscript.
: This study was approved by the local ethics committees of the participating sites and performed in accordance with the ethical standards laid down in the Declaration of Helsinki of 1964 and its later amendments.
: Participants’ written informed consent was obtained prior to any study related procedures.